Hutch News
Results per Page:
Future of medicine: Body heal thyself
Panel of Hutch scientists talked gene therapy, big data and financial toxicity to reporters at annual AAAS meeting
Fred Hutch at ASCO: HPV vaccine uptake in U.S., immunotherapy and sarcoma, financial toxicity of cancer, health care disparities and more
The American Society of Clinical Oncology will hold its annual meeting May 31-June 4 in Chicago
New data on cancer disparities in Washington
Health equity, patient voices and patient-engaged research hot topics at Value in Cancer Care Summit
Dr. Veena Shankaran named 2019 Leader in Health Care
Seattle Business magazine honors oncologist, health services researcher
Dr. Veena Shankaran joins leadership of Fred Hutch’s health care economics and policy research institute
She will contribute to strategic planning, scientific priority setting, fundraising and organizational development
Fred Hutch at ASCO
Immunotherapy advances, insights into health economics and leadership awards dominate oncology gathering
At half the cost, Canadian colorectal cancer survival similar to that of U.S.
Cross-border collaboration compared findings in British Columbia and Washington state
Good News: Dr. Jen Adair speaks on gene therapy at TEDxNashville
Celebrating faculty and staff achievements
Good News: 8 Fred Hutch/UW researchers receive pilot awards
Celebrating faculty and staff achievements
As U.S. cases of skin cancer rise, costs skyrocket, too
Five million American adults are diagnosed each year at a cost of $8.1 billion, new CDC study finds
Fred Hutchinson Cancer Research Center researcher Veena Shankaran to receive ‘40 Under 40’ award
Puget Sound Business Journal will honor Shankaran and others as top leaders in their fields
Ostronoff, Shankaran win two-year SWOG research grants
Fred Hutchinson Cancer Research Center investigators are among three recipients of $100,000 Coltman Fellowships from SWOG, formerly known as the Southwest Oncology Group
Clinical gains gastrointestinal oncologist
Cancer clinician Veena Shankaran studies costs, effectiveness of cancer therapies